The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “September 2019” and All Insider Sales to “$200,000+.”
According to these filters, the following are trades from company insiders this week.
The Tiger Global Long Opportunities Fund bought 859,897 shares of Sunrun Inc. (RUN, Financial) for an average price of $17.24 per share on Sept. 19.
The solar energy services provider has a market cap of $2.05 billion and an enterprise value of $4.39 billion. It has insider ownership of 7.18% and institutional ownership of 97.21%.
Over the past 12 months, the stock has risen 39.68% and, as of Friday, was trading 18.49% below its 52-week high and 98.18% above its 52-week low.
Ronald O. Perelman bought 606,061 shares of vTv Therapeutics Inc. (VTVT, Financial) for an average price of $1.65 per share on Sept. 18.
The company, which develops orally administered small molecule drug candidates, has a market cap of $97.28 million and an enterprise value of $106.83 million. It has insider ownership of 0.24% and institutional ownership of 10.07%.
Over the past 12 months, the stock has risen 110% and, as of Friday, was trading 71.62% below its 52-week high and 130.44% above its 52-week low.
Rajeev M. Shah, director and 10% owner, and Ken Takanashi, director, together with 10% owner RA Capital Healthcare Fund LP and TPG Group Holdings (SBS) Advisors bought a combined 2.99 million shares of Satsuma Pharmaceuticals Inc. (STSA) for an average price of $15 per share on Sept. 17.
The clinical-stage biopharmaceutical company has a market cap of $257.88 million and an enterprise value of $207.87 million.
Over the past 12 months, the stock has fallen 8.22%.
Mitchell S. Felder, chairman and 10% owner of Premier Biomedical Inc. (BIEI, Financial), bought 1 million shares for an average price of one cent per share on Sept. 16.
The specialty drugmaker has a market cap of $220,000 and an insider ownership of 5.75%.
Over the past 12 months, the stock has fallen 94.72% and, as of Friday, was trading 94.83% below its 52-week high and 116% above its 52-week low.
Jorge P. Lemann, director of The Kraft Heinz Co. (KHC, Financial), bought 3.49 million shares for an average price of $28.60 per share on Sept. 16.
The food and beverage company has a market cap of $34.66 billion and an enterprise value of $64.47 billion. It has institutional ownership of 71.72% and insider ownership of 0.2%.
Over the past 12 months, the stock has fallen 50.60% and, as of Friday, was trading 51.28% below its 52-week high and 13.82% above its 52-week low.
Most important insider sales
Michael Patrick Byrne, 10% owner of Overstock.com Inc. (OSTK, Financial), sold 4.07 million shares for an average price of $19.15 per share on Sept. 18.
The online retailer has a market cap of $571.33 million and an enterprise value of $574.77 million. It has insider ownership of 6.09% and institutional ownership of 81.35%.
Over the past 12 months, shares have fallen 39.02%. As of Friday, the stock was trading 49.41% below its 52-week high and 67.97% above its 52-week low.
Amanda MK Trust, 10% owner of National Research Corp. (NRC), sold 500,000 shares for an average price of $60.50 per share on Sept. 18.
The company, which operates in the medical diagnostics and research industry, has a market cap of $1.57 billion and an enterprise value of $1.60 billion. It has insider ownership of 2.12% and institutional ownership of 57.76%.
Over the past 12 months, the share price has risen 64.71% and, as of Friday, was trading 8.51% below its 52-week high and 77.07% above its 52-week low.
John Kristofer Galashan and Jonathan A. Seiffer sold a combined 6.01 million shares of GMS Inc. (GMS, Financial) for an average price of $25.68 per share on Sept. 17.
The company has a market cap of $3.59 billion and an enterprise value of $7.38 billion. It has insider ownership of 1.07% and institutional ownership of 77.04%.
Over the past 12 months, the stock has fallen 9.46% and, as of Friday, was trading 11.6% below its 52-week high and 35.99% above its 52-week low.
Disclosure: I do not own any stocks mentioned.
Read more here:
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
